Turkey of the week: hedge-fund provider won't escape turmoil
Fears over the health of the financial system intensified last week on the back of a deteriorating US employment picture. These worries once again pushed up inter-bank lending rates (ie, Libor), which in turn upped the pressure on the hedge-fund industry. When credit was booming and the cost of borrowing was cheap, many hedge funds loaded up on debt, using it to ratchet up their returns. Now banks are demanding loans be repaid when investments turn sour and funds are being forced to off-load assets at rock-bottom prices to raise cash. Clearly, this is good news for stock-pickers like myself, since it generates excellent buying opportunities. For the hedge industry, however, it is excruciating: many funds are going bust and the reputation of the remainder is hardly being enhanced.
To read the rest of this article in full, just click here now for your
3-week FREE TRIAL - giving you:
- FREE! - read the rest of this article now.
- FREE! - immediate access to the entire website, with all our money-making tips, news, advice and articles, continuing for the next 3 weeks.
- FREE! - our punchy daily investment email "Money Morning", with our insights and ascerbic views on the day's financial news, plus...
- FREE! - our award-winning magazine, with all the latest financial news, developments, and essential advice for investors, delivered to your door for the next 3 weeks.
Sir Antony Jay
"I started with £3,000 and have doubled it to date, using a combination of tips in the 'at a glance' section." Fred McKenzie
"If you are a serious investor, you should be reading MoneyWeek." Rupert Foster, Chief Executive, FM Capital Management
"I bought into four European emerging markets funds following general info from your magazine, and so far I have achieved 25% gains." K Murphy, London
"Money Week encouraged me to go 100% oil, and I have gone £38K to £62K in a year." Garry Morrow, N Ireland
Don't miss this opportunity to join these successful investors! For your 3-week FREE trial - sign up here







